STXS 2.92 ▲ 0.00% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Stereotaxis Inc.

    AMEX: STXS · Real-Time Price · USD
    2.92
    0.00 (0.00%)
    At close: Sep 26, 2025, 10:58 AM
    0.00%
    Bid 2.91
    Market Cap 263.75M
    Revenue (ttm) 31.81M
    Net Income (ttm) -23.35M
    EPS (ttm) -0.29
    PE Ratio (ttm) -10.05
    Forward PE -16.31
    Analyst n/a
    Dividends n/a
    Ask 2.93
    Volume 43,586
    Avg. Volume (20D) 529,282
    Open 2.95
    Previous Close 2.92
    Day's Range 2.89 - 2.96
    52-Week Range 1.54 - 3.07
    Beta 1.61
    Ex-Dividend Date n/a

    About STXS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol STXS
    Website n/a
    Full Company Profile

    Next Earnings Release

    Stereotaxis Inc. is scheduled to release its earnings on Nov 10, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 months ago
    +15.11%
    Stereotaxis shares are trading higher after the co... Unlock content with Pro Subscription
    2 months ago
    -0.42%
    Stereotaxis shares are trading lower after the company announced a $12.5 million registered direct offering.
    news image

    3 days ago · zacks.com

    STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System

    Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.

    news image

    3 weeks ago · zacks.com

    STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep

    Stereotaxis debuts MAGiC Sweep, the first U.S. robotic HD mapping catheter, marking a breakthrough in cardiac arrhythmia diagnosis and treatment.

    news image

    1 month ago · seekingalpha.com

    Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

    Stereotaxis, Inc. (NYSE:STXS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants David Leo Fischel - CEO & Chairman Kimberly R. Peery - Chief Financial Officer Conference...

    news image

    1 month ago · zacks.com

    Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates

    Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.07 per share a year ago.

    news image

    1 month ago · zacks.com

    Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know

    Stereotaxis (STXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    2 months ago · zacks.com

    Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial

    STXS posts first peer-reviewed results for its MAGiC catheter, showing 94% efficacy and strong safety in arrhythmia treatment.

    news image

    2 months ago · seekingalpha.com

    Stereotaxis: Recurring Revenue Inflection

    I rate Stereotaxis Strong Buy, with 85% upside to $4 PT, driven by underappreciated recurring revenue and regulatory catalysts. Recurring revenue is inflecting above 25% growth, with high-margin dispo...

    Add to Watchlist